Nutri Biotech Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nutri Biotech Co Ltd with three other
companies in this sector in South Korea:
Celltrion Pharm Incorporated
sales of 135.86 billion Korean Won [US$119.96 million]
of which 100%
Dae Han New Pharm Co., Ltd.
(130.82 billion Korean Won [US$115.51 million]
Myungmoon Pharmaceutical Company Limited
(140.14 billion Korean Won [US$123.74 million]
of which 97%
was Manufacture and Sale of Pharmaceuticals).
During the year ended December of 2017, sales at
Nutri Biotech Co Ltd were 136.35 billion Korean Won (US$120.40 million).
increase of 12.9%
versus 2016, when the company's sales were 120.78 billion Korean Won.
This was the fifth consecutive year of sales increases at Nutri Biotech Co Ltd
(and since 2012, sales have increased a total of 343%).